This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/usa/543582-pfizer-booster-test-children/
The article has changed 2 times. There is an RSS feed of changes available.
Previous version
1
Next version
Version 0 | Version 1 |
---|---|
Pfizer to test Covid booster dose on infants, young kids | Pfizer to test Covid booster dose on infants, young kids |
(about 4 hours later) | |
Pfizer will start testing Covid-19 vaccine booster doses in children aged six months to five years old after finding that its lower-dose shot may not provide enough protection in one age group. | Pfizer will start testing Covid-19 vaccine booster doses in children aged six months to five years old after finding that its lower-dose shot may not provide enough protection in one age group. |
The pharmaceutical giant announced on Thursday that it would start testing a third dose on young children “at least two months after the second dose” in an effort “to provide high levels of protection in this young age group.” | The pharmaceutical giant announced on Thursday that it would start testing a third dose on young children “at least two months after the second dose” in an effort “to provide high levels of protection in this young age group.” |
Explaining its decision, the company cited clinical data showing that the smallest ‘baby’ dose administered to children under five does not appear to be effective in protecting those in the 2-to-5 age bracket. | |
Vaccine doses vary across different age groups involved in the study. Children aged 5-12 received two 10-microgram doses – one-third of the adult 30-microgram dose. Children younger than five, including infants, were vaccinated with three-microgram shots. | |
Pfizer claimed that no safety concerns were identified during the trial, and said it would seek emergency authorization of the new three-dose vaccination regimen for young children next year, provided the three-dose study is a success. | |
The announcement comes after the US Centers for Disease Control and Prevention (CDC) this week reported eight cases of myocarditis, a potentially deadly heart inflammation, in children aged 5-11 years old after they received the Pfizer vaccine. | The announcement comes after the US Centers for Disease Control and Prevention (CDC) this week reported eight cases of myocarditis, a potentially deadly heart inflammation, in children aged 5-11 years old after they received the Pfizer vaccine. |
As of November, everyone in the US aged five and above is eligible to be vaccinated for Covid-19. Americans who are at least 16 are also eligible for a Pfizer booster, while those 18 and above can receive a booster from Moderna or Johnson & Johnson. |
Previous version
1
Next version